These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5041043)

  • 21. [Clinical picture, morphology and pathogenesis of congenital liver diseases with giant-cell formation].
    Willnow U
    Arch Kinderheilkd; 1971 Jan; 82(2):153-68. PubMed ID: 5099763
    [No Abstract]   [Full Text] [Related]  

  • 22. [Glycogenosis of the liver with galactose utilization disorder and a severe Fanconi syndrome].
    Lampert F; Mayer H
    Z Kinderheilkd; 1967; 98(2):133-45. PubMed ID: 5230448
    [No Abstract]   [Full Text] [Related]  

  • 23. [The oral galactose tolerance as a liver function test. Clinical-experimental studieson the prolem of dosage].
    Rommel K; Grimmel K
    Med Klin; 1967 Feb; 62(5):168-71. PubMed ID: 5590185
    [No Abstract]   [Full Text] [Related]  

  • 24. [Disorders of glucose tolerance in 2600 histologically confirmed acute and chronic liver patients (author's transl)].
    Mütting D; Kaufmann M
    MMW Munch Med Wochenschr; 1975 Oct; 117(42):1689-94. PubMed ID: 810695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Editorial: Biopsy in alcoholic liver disease.
    Lough J
    Can Med Assoc J; 1974 May; 110(10):1121 passim. PubMed ID: 4829830
    [No Abstract]   [Full Text] [Related]  

  • 26. [Intravenous loading with galactose as a liver function test. Methods and clinical value].
    Kuntz HD; Kuntz E
    Fortschr Med; 1983 Jun; 101(21):999-1004. PubMed ID: 6873856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On liver cirrhosis in an infant with galactosemia].
    ROSCHLAU G
    Zentralbl Allg Pathol; 1962 May; 103():364-75. PubMed ID: 14493813
    [No Abstract]   [Full Text] [Related]  

  • 28. Iron storage disorders of the liver.
    Grace ND; Powell LW
    Gastroenterology; 1974 Dec; 67(6):1257-83. PubMed ID: 4609829
    [No Abstract]   [Full Text] [Related]  

  • 29. [Intravenous galactose tolerance test as liver function test].
    Rommel K; Böhmer R; Adam WE
    Schweiz Med Wochenschr; 1967 Apr; 97(15):484-7. PubMed ID: 5585388
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies on bilirubin glucuronide. I. A study on the relation of bilirubin glucuronide in bile and liver damage].
    Takagi M
    Igaku Kenkyu; 1969 Jun; 39(3):255-64. PubMed ID: 5389947
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparative evaluation of tolerance tests with sulfobromophthalein and with galactose in chronic liver diseases. (Value and limitations of the discriminating analyses used in the 2 tests for diagnosis of hepatic cirrhosis)].
    Coltorti M; Di Simone A; Budillon G; Carrella M; Oriani G
    Policlinico Med; 1968; 75(4):189-215. PubMed ID: 5708459
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of intravenous and peroral galactose elimination tests with and without ethanol in different clinical conditions.
    Kesäniemi YA; Kurppa KO; Salaspuro MP
    Scand J Gastroenterol; 1973; 8(7):593-8. PubMed ID: 4768306
    [No Abstract]   [Full Text] [Related]  

  • 33. [Long-term prognosis in chronic liver diseases].
    Becker K
    Wien Med Wochenschr; 1980 Sep; 130(17):549-54. PubMed ID: 7006222
    [No Abstract]   [Full Text] [Related]  

  • 34. [Surgical experiences with 131-I-rose Bengal studies of liver and biliary tract].
    Tóth C; Lévai F
    Zentralbl Chir; 1968 Jun; 93(25):870-3. PubMed ID: 5682183
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical significance of laboratory indicators in patients with chronic liver diseases].
    Bondar' ZA; Podymova SD; Zolotnitskaia RP; Saluznía AI; Plotnikova NM
    Sov Med; 1974 Jun; 37(6):37-43. PubMed ID: 4846469
    [No Abstract]   [Full Text] [Related]  

  • 36. Tyrosine metabolism in patients with liver disease.
    Levine RJ; Conn HO
    J Clin Invest; 1967 Dec; 46(12):2012-20. PubMed ID: 6074004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Zinc and liver diseases].
    Kment M; Cikrt M
    Cesk Gastroenterol Vyz; 1978 Mar; 32(2):131-7. PubMed ID: 350434
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatic copper content, urinary copper excretion, and serum ceruloplasmin in liver disease.
    Ritland S; Steinnes E; Skrede S
    Scand J Gastroenterol; 1977; 12(1):81-8. PubMed ID: 834974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnostic validity of the intravenous galactose tolerance test in liver cirrhosis (author's transl)].
    Böhmer R; Rommel K
    Acta Hepatogastroenterol (Stuttg); 1972; 19(5):344-56. PubMed ID: 4668529
    [No Abstract]   [Full Text] [Related]  

  • 40. [Jaundice].
    Iakhontova OI; Rutgaĭzer IaM; Valenkevich LN
    Klin Med (Mosk); 1998; 76(10):59-64. PubMed ID: 9865023
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.